biotin has been researched along with dalteparin in 3 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (dalteparin) | Trials (dalteparin) | Recent Studies (post-2010) (dalteparin) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 5,665 | 1,423 | 2,267 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eikelboom, JW; Weitz, JI | 1 |
| Büller, HR; Gallus, AS; Pillion, G; Prins, MH; Raskob, GE | 1 |
| Buerke, M; Drouget, L; Hauroeder, B; Kaeberich, A; Krezel, C; Maedgefessel, L; Neuhart, E; Raaz, U; Schlitt, A; Vogt, A; Werdan, K | 1 |
2 trial(s) available for biotin and dalteparin
| Article | Year |
|---|---|
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Biotin; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Factor X; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Oligosaccharides; Pulmonary Embolism; Warfarin | 2012 |
In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated heparin, enoxaparin, and fondaparinux in preventing cardiac catheter thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Biotin; Cardiac Catheters; Enoxaparin; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Male; Middle Aged; Oligosaccharides; Polysaccharides; Prothrombin; Thrombosis | 2014 |
1 other study(ies) available for biotin and dalteparin
| Article | Year |
|---|---|
Idrabiotaparinux treatment for venous thromboembolism.
Topics: Anticoagulants; Biotin; Enoxaparin; Factor X; Female; Humans; Male; Oligosaccharides; Pulmonary Embolism; Warfarin | 2012 |